dehydroepiandrosterone sulfate has been researched along with Adenocarcinoma, Clear Cell in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Giraud, P; Guyétant, S; Lorimier, G; Sommelet, D; Valo, I; Verrièle, V | 1 |
Bennett, P; Blaakaer, J; Bock, J; Daugaard, S; Høgdall, CK; Hørding, U; Toftager-Larsen, K | 1 |
2 other study(ies) available for dehydroepiandrosterone sulfate and Adenocarcinoma, Clear Cell
Article | Year |
---|---|
[Thyroid metastases of an adrenocortical carcinoma 41 years after the diagnosis of the primary tumor].
Topics: Adenocarcinoma, Clear Cell; Adrenal Cortex Neoplasms; Adrenalectomy; Antineoplastic Agents; Biomarkers, Tumor; Combined Modality Therapy; Dehydroepiandrosterone Sulfate; Humans; Hydrocortisone; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Mitotane; Nephrectomy; Radiotherapy, Adjuvant; Thyroid Neoplasms; Thyroidectomy; Time Factors | 2004 |
Hormonal factors and prognosis in epithelial ovarian cancer: a multivariate analysis.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Aging; Androstenedione; Carcinoma, Endometrioid; Cystadenocarcinoma, Serous; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Female; Follicle Stimulating Hormone; Hormones; Humans; Luteinizing Hormone; Multivariate Analysis; Neoplasm Staging; Ovarian Neoplasms; Progesterone; Prognosis; Regression Analysis; Testosterone | 1993 |